RecruitingNot ApplicableNCT06127511

Peanut Consumption on Cognitive, Weight, and Inflammation

Peanut Consumption on Cognitive Performance, Weight Management, and Inflammation in Young Adolescents


Sponsor

University of Barcelona

Enrollment

200 participants

Start Date

Jan 29, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

A multi-school, two-arm parallel cluster-randomized controlled trial will be conducted in 200 healthy young adolescents from Barcelona (Spain) to evaluate the effect of peanut consumption on cognitive performance, weight management and inflammation. Schools willing to participate will be randomly assigned to either the intervention or the control group. After the recruitment, the participants will follow a peanut-free diet for two weeks. Both arms will receive a multidimensional educational intervention designed by the Gasol Foundation to promote healthy dietary habits based on Mediterranean diet recommendations, along with exercise performance, healthy sleeping habits and emotional knowledge. Half of the participants (intervention group) will consume 25 g of whole skin roasted peanuts as a daily snack to be incorporated into their diet for six months.


Eligibility

Min Age: 10 YearsMax Age: 12 Years

Inclusion Criteria1

  • Eligible participants will be young adolescents, boys and girls, aged between 10 and 12 years who attend regular primary schools in Barcelona. The schools will assist with the participant recruitment through the classes and after that, a total of one-hundred students will be randomly included in each group. In all cases, participation will be voluntary and informed consent will be obtained prior to the study.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERFood (peanut)

After the recruitment, the participants will follow a peanut-free diet for two weeks.


Locations(1)

IDIBAPS

Barcelona, Barcelona, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06127511


Related Trials